CMS Maintains Status Quo On Clinical Trial Coverage, Again
This article was originally published in The Gray Sheet
Executive Summary
Under intense pressure from Congress, industry and the medical research community, CMS has decided to maintain the status quo for coverage of routine costs in clinical trials